2017 Research Annual Report


Featured Research

Lowering Dosage of Retinopathy Injection Treatment Did Not Decrease Effectiveness Intravitreous bevacizumab has become an increasingly common way to treat retinopathy of prematurity (ROP) in infants, but systemic toxicity remains one of its potentially dangerous side effects.

Read Featured Research

Division Summary

Research and Training Details
Faculty 14
Joint Appointment Faculty 1
Research Fellows and Post Docs 9
Research Graduate Students 2
Total Annual Grant Award Dollars $1,038,537
Clinical Activities and Training
Staff Physicians 1
Clinical Fellows 1
Inpatient Encounters 2,040
Outpatient Encounters 32,294